Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer

Neighborhood-Level Disadvantage and Delayed A...

Up next

Deep Learning in Otolaryngology

Interview with Amal Isaiah, MD, PhD, MBA, author of Deep Learning in Otolaryngology: A Narrative Review, and Matthew A. Shew, MD, MSCI, author of Shifting the AI Questions in Otolaryngology From "Can We Build a Model?" to "Will It Improve Patient Care?" Hosted by Paul C. Bryson, ...  Show more

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer

Interview with Baran D. Sumer, MD, and Lauren Gabra, MD, authors of Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Body Mass Index and Nutritional Status With Immunotherapy Response i ...  Show more

Recommended Episodes

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
JAMA Oncology Author Interviews

Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD.

Related Content:

<ul> <li><a class="related-article" href= "https://jamanetwork.com/journal ...  Show more

Ep. 245 Understanding Keynote-689: Immunotherapy for Head & Neck Cancer with Dr. Dylan Roden, Dr. Ravi Uppaluri and Dr. Adam Luginbuhl
BackTable ENT & Allergy

While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using perioperative pembrolizumab is forcing clinicians to rethink their entire workflow, starting with diagnosis. In this episode of the BackTable Podcast, head and neck surgica ...  Show more

Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Coronavirus (COVID-19) Q&A

Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction 

3D Total-Body Photography in Patients at High Risk for Melanoma
JAMA Dermatology Author Interviews

Interview with Monika Janda, PhD, author of 3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD. Related Content: 3D Total-Body Photography in Patients at High Risk for Melanoma